North America Maternal Mental Health Market Size, Share & Trends Analysis Report By Disease Indication (Postpartum Depression, Dysthymia), By Therapy (Interpersonal Psychotherapy, Antidepressants), By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective - 1
1.2.2. Objective - 2
1.2.3. Objective - 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Gvr’s Internal Database
1.4.3.第二手来源
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Disease Indication and Therapy Snapshot 1
2.3. Competitive Landscape Snapshot
Chapter 3. North America Maternal Mental Health Market Variables and Trends
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Impact Analysis
3.2.1.1. Rise in government funding to reduce the maternal mortality
3.2.1.2. Increasing incidence of post-partum depression
3.2.1.3. Rise in awareness programs and efforts to improve practices around maternal mental healthcare
3.2.2. Market Restraint Impact Analysis
3.2.2.1. Mental health workforce shortage
3.2.2.2. Social stigma surrounding postpartum depression
3.3. Impact of the COVID-19 Pandemic
3.4. Industry Analysis Tools
3.4.1. Porter’s Analysis
3.4.2. Swot Analysis; By Factor (Political & Legal, Economic And Technological)
Chapter 4. North America Maternal Mental Health Market: Disease Indication Estimates & Trend Analysis
4.1. Disease Indication Movement Analysis & Market Share, 2022 & 2030
4.2. North America Maternal Mental Health Market Estimates & Forecast, By Disease Indication (USD Million)
4.3. Postpartum Depression
4.3.1. Global Postpartum Depression Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4. Dysthymia
4.4.1. Global Dysthymia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.5. Pregnancy and Postpartum General Anxiety
4.5.1. Global Pregnancy And Postpartum General Anxiety Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.6. Pregnancy and Postpartum OCD
4.6.1. Global Pregnancy And Postpartum OCD Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.7. Birth-Related PTSD
4.7.1. Global Birth-Related PTSD Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.8. Others
4.8.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5. North America Maternal Mental Health Market: Therapy Estimates & Trend Analysis
5.1. Therapy Movement Analysis & Market Share, 2022 & 2030
5.2. North America Maternal Mental Health Market Estimates & Forecast, By Therapy (USD Million)
5.3. Antidepressants
5.3.1.Global Antidepressants Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.3.2. Selective Serotonin Reuptake Inhibitors (SSRIs)
5.3.2.1. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.3.3. Tricyclic Antidepressants (TCAs)
5.3.3.1. Global Tricyclic Antidepressants (TCAs) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.3.4. Others
5.3.4.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.4. Interpersonal Psychotherapy (IPT)
5.4.1. Global Interpersonal Psychotherapy (IPT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5. Cognitive Behavioral Therapy (CBT)
5.5.1. Global Cognitive Behavioral Therapy (CBT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 6. North America Maternal Mental Health Market: Regional Estimates and Trend Analysis
6.1. North America Maternal Mental Health Market: Regional Outlook
6.2. North America
6.2.1. North America Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. Competitive Scenario
6.2.2.3. Regulatory Framework
6.2.2.4. U.S. North America Maternal Mental Health Market Estimates and Forecasts, 2018 - 2030 (USD MILLION)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Competitive Scenario
6.2.3.3. Regulatory Framework
6.2.3.4. Canada North America Maternal Mental Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. North America Maternal Mental Health Market: Competitive Landscape
7.1. Participant Categorization
7.1.1. Therapy Mama
7.1.1.1. Overview
7.1.1.2. Product Benchmarking
7.1.1.3. Strategic Initiatives
7.1.2. Canopie
7.1.2.1. Overview
7.1.2.2. Product Benchmarking
7.1.2.3.战略行动
7.1.3. Pfizer Inc
7.1.3.1. Overview
7.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Viatris Inc.
7.1.4.1. Overview
7.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. GlaxoSmithKline Inc.
7.1.5.1. Overview
7.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Alembic Pharmaceuticals Limited
7.1.6.1. Overview
7.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Mallinckrodt Inc.
7.1.7.1. Overview
7.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Sage Therapeutics, Inc.
7.1.8.1. Overview
7.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. Bausch Health Companies Inc.
7.1.9.1. Overview
7.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Magellan Health, Inc.
7.1.10.1.概述
7.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives
7.2. Participant’s Overview
7.3. Financial Performance
7.4. Product Benchmarking
7.5. Company Market Share Analysis, 2022
7.6. Strategy Mapping
7.6.1. Expansion
7.6.2. Acquisition
7.6.3. Product/Service Launch
7.6.4. Others
Chapter 8. Analyst View

List of Tables

表1List of secondary sources
Table 2 List of Abbreviations
Table 3 North America maternal mental health market, by region, 2018 - 2030 (USD Million)
Table 4 North America maternal mental health market, by disease indication, 2018 - 2030 (USD Million)
Table 5 North America maternal mental health market, by therapy, 2018 - 2030 (USD Million)
Table 6 North America maternal mental health market, by country, 2018 - 2030 (USD Million)
Table 7 North America maternal mental health market, by disease indication, 2018 - 2030 (USD Million)
Table 8 North America maternal mental health market, by therapy, 2018 - 2030 (USD Million)
Table 9 U.S. maternal mental health market, by disease indication, 2018 - 2030 (USD Million)
表10 U.S. maternal mental health market, by therapy, 2018 - 2030 (USD Million)
表11 Canada maternal mental health market, by disease indication, 2018 - 2030 (USD Million)
表12 Canada maternal mental health market, by therapy, 2018 - 2030 (USD Million)
表13 Company Overview
表14 Financial Performance
表15 Product Benchmarking
表16 Strategic Initiatives

List of Figures

Fig. 1 Maternal Mental Health market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market Outlook (2022)
Fig. 10 Segment Outlook
Fig. 11 Strategy framework
Fig. 12 Market driver relevance analysis (current & future impact)
Fig. 13 Market restraint relevance analysis (current & future impact)
Fig. 14 Porter’s five forces analysis
Fig. 15 Swot analysis, by factor (political & legal, economic and technological)
Fig. 16 North America maternal mental health market: disease indication movement analysis
Fig. 17 North America maternal mental health market, for postpartum depression, 2018 - 2030 (USD million)
Fig. 18 North America maternal mental health market, for dysthymia, 2018 - 2030 (USD million)
Fig. 19 North America maternal mental health market, for pregnancy and postpartum general anxiety, 2018 - 2030 (USD million)
Fig. 20 North America maternal mental health market, for pregnancy and postpartum OCD, 2018 - 2030 (USD million)
Fig. 21 North America maternal mental health market, for birth-related PTSD, 2018 - 2030 (USD million)
Fig. 22 North America maternal mental health market, for others, 2018 - 2030 (USD million)
Fig. 23 North America maternal mental health market: therapy movement analysis
Fig. 24 North America maternal mental health market, for antidepressants, 2018 - 2030 (USD million)
Fig. 25 North America maternal mental health market, for selective serotonin reuptake inhibitors, 2018 - 2030 (USD million)
Fig. 26 North America maternal mental health market, for tricyclic antidepressants, 2018 - 2030 (USD million)
Fig. 27 North America maternal mental health market, for others, 2018 - 2030 (USD million)
Fig. 28 North America maternal mental health market, for interpersonal psychotherapy, 2018 - 2030 (USD million)
Fig. 29 North America maternal mental health market, for cognitive behavioral therapy, 2018 - 2030 (USD million)
Fig. 30 North America maternal mental health market, for others, 2018 - 2030 (USD million)
Fig. 31 Regional marketplace: key takeaways
Fig. 32 Regional outlook, 2022 & 2030
Fig. 33 North America maternal mental health market: region movement analysis
Fig. 34 North America maternal mental health market, 2018 - 2030 (USD million)
Fig. 35 U.S. Maternal mental health market, 2018 - 2030 (USD million)
Fig. 36 Canada maternal mental health market, 2018 - 2030 (USD million)